SNDL Inc. (SNDL) stock
SNDLNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$1.34+0.00 (0.00%)
Close on Nov 17, 2026Market cap $352.90MP/E –Yield –
Earnings
SNDL's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q4 FY2026
C$252.50M
EPS, Q4 FY2026
–
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of SNDL's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2025 | Mar 12, 2026before the open | C$252.50M | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
SNDL has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When SNDL puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases SNDL filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
See a number that looks wrong?